Congress just gave the hemp industry a two‑year lifeline, pushing the federal restriction deadline to December 11, 2026. The new law preserves access to naturally derived hemp products while buying time for a comprehensive regulatory framework.
Federal Law Delays Hemp Restrictions Until 2026
President Trump signed the legislation on September 1, extending the deadline from November 12 to December 11, 2026 and giving Congress extra time to craft a comprehensive regulatory framework.
A More Sustainable Regulatory Framework
CV Sciences CEO Joseph Dowling said the extension offers a vital opportunity to establish clear, science‑based standards that protect consumers while keeping responsibly manufactured hemp products on the market.
“We welcome the enactment of this legislation and the additional time it provides for Congress to get the regulatory framework right,” Dowling said. “Consumers deserve products that are accurately labeled, rigorously tested, and transparently marketed.”
The company argues that a durable framework should distinguish naturally derived hemp products from synthetic or inappropriate cannabinoid items, ensuring safety and consistency across the supply chain.
CV Sciences will continue to work with policymakers, industry groups and stakeholders as the long‑term regulatory discussion progresses.
CV Sciences, a San Diego‑based consumer wellness firm, markets hemp extracts under the +PlusCBD™ brand and other plant‑based supplements, noting that the temporary extension safeguards its business and the broader industry.
